Evidence map›Paper›PMID 41329781›Full record

ArticlePLoS pathogens2025

Polo-like kinase 1 regulates growth in juvenile Fasciola hepatica.

Paul McCusker, Nathan G Clarke, Rebecca Armstrong, Duncan Wells, Emily Robb, Paul McVeigh, Andreas Krasky, John Harrington, Paul M Selzer, Nikki J Marks and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A practical miracidial motility assay for assessing Fasciola hepatica sensitivity to compounds in vitro.International journal for parasitology. Drugs and drug resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paul McCuskerUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0003-0030-1594
Nathan G ClarkeUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Rebecca ArmstrongUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Duncan WellsUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Emily RobbUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Paul McVeighUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Andreas KraskyBoehringer Ingelheim Animal Health, Ingelheim am Rhein, Germany.
John HarringtonBoehringer Ingelheim Animal Health, Athens, Georgia, United States of America.
Paul M SelzerBoehringer Ingelheim Animal Health, Ingelheim am Rhein, Germany.
Nikki J MarksUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Aaron G MauleUnderstanding Health & Disease, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/T002727/1
6 · The paper itself

Abstract

Fasciola sp. (liver fluke) are parasitic flatworms that impose a significant burden on the agri-food industry and human health. Immature worms can cause severe damage to the liver as they migrate towards the bile ducts, and yet there is only a single drug to treat this pathogenic life stage, driving the need to identify targets for novel flukicides. Given their crucial role in the growth/development of immature Fasciola hepatica, neoblast-like stem cells are an attractive source of new flukicide targets. Kinases are a hugely diverse group of phosphorylating enzymes with key roles in almost all cellular processes. Kinase dysregulation can result in the development of cancerous cells/tissues, linking many to cell cycle-associated proliferation and growth. Here, we annotate the F. hepatica kinome, identifying 271 putative protein kinases, representing around 1.6% of predicted F. hepatica protein-coding genes with family proportions similar to those of other parasitic flatworms. Many of these kinases, such as polo-like kinase 1 (fhplk1), are upregulated in immature worms undergoing rapid growth and development, a process underpinned by the proliferation of neoblast-like stem cells. RNA interference (RNAi)-mediated silencing of fhplk1 in juvenile liver fluke reduced growth and cell proliferation, suggesting a conserved role within the cell-cycle; the cessation of stem cell proliferation persisted for at least a week following fhplk1-RNAi. A PLK inhibitor (BI 2536) was shown to phenocopy the fhplk1-RNAi phenotype in a dose-dependent manner, supporting the feasibility of targeting F. hepatica neoblast-like cells through kinase inhibitors. Transcriptomic analysis of fhplk1-RNAi juveniles revealed 946 downregulated genes, principally associated with the cell cycle or ribosomes. Over 80 of these downregulated genes were also downregulated following juvenile F. hepatica irradiation, supporting roles for these kinases in neoblast-like stem cells, and marking them as putative targets for control. Among the 1244 upregulated genes in fhplk1-RNAi juvenile worms were many neurotransmitters, receptors and ion channels, exposing the apparent upregulation of diverse inter-cellular signalling systems. While many neurotransmitter pathways promote proliferation in mammalian systems the interaction between neoblast-like stem cells and neuronal signalling in parasitic flatworms remains elusive. Here, the transcriptomic response of fhplk1-RNAi juveniles supports a link between neoblast-like stem cell driven growth/development and neuronal signalling.

Indexed as

Cell Cycle ProteinsFasciola hepaticaFascioliasisHelminth ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsAnimalsCell ProliferationPolo-Like Kinase 1Cell Cycle ProteinsHelminth ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene Proteins

Identifiers

PMID41329781
PMCPMC12688102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.